CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- 4 Open-market sale Director sold 5,000 shares at an average $57.92 ($289,622)
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at $60.90 ($243,600)
- 4 Open-market sale Director sold 15,833 shares at an average $61.52 ($974,082)
- 4 Open-market sale President and CEO sold 16,412 shares at an average $53.38 ($876,008)
- 4 Open-market sale Director sold 10,000 shares at $48.09 ($480,900)
- 4 Open-market sale Director sold 25,000 shares at $48.09 ($1,202,250)
- 4 Open-market sale Director sold 31,666 shares at $48.09 ($1,522,818)
- 4 Open-market sale President and CEO sold 2,720 shares at $32.02 ($87,090)
- 4 Open-market sale Chief Strategy Officer and CFO sold 10,000 shares at $30.75 ($307,496)
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at $30.00 ($120,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Strategy Officer and CFO sold 10,000 shares at $30.17 ($301,672)
- 4 Open-market sale President and CEO sold 2,181 shares at $32.03 ($69,855)
- 4 Open-market sale President and CEO sold 34,925 shares at an average $32.15 ($1,122,945)
- 4 Open-market sale President and CEO sold 42,460 shares at an average $32.51 ($1,380,380)
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at $30.52 ($122,080)
- 4 Open-market sale President and CEO sold 376 shares at $32.00 ($12,032)
- 4 Open-market sale Chief Strategy Officer and CFO sold 70,000 shares at an average $32.54 ($2,277,788)
- 4 Open-market sale Director sold 15,000 shares at $32.90 ($493,500)
Page 10 of 25 · 488 filings